DJ
Dharmendra Jain
About Dharmendra Jain
Data last updated:
Dharmendra Jain is a Managing Director at Synchem Pharmaceuticals Private Limited (since 2000) and Designated Partner at Muskan Petro Chemical Llp (since 2024). The companies operate in Pharma and Energy and Power. The largest current company by reported revenue is Synchem Pharmaceuticals Private Limited at ₹53.59 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Synchem Pharmaceuticals Private Limited U24239MP2000PTC051978 | Managing Director | 19 Apr 2000 | 2000 | ₹53.59 Cr (FY 2025) | Active |
 Muskan Petro Chemical Llp ACB-7691 | Designated Partner | 20 Nov 2024 | 2023 | Active |
Board colleagues of Dharmendra Jain
| Name | DIN | Company | Designation |
|---|---|---|---|
| Dinesh Kumar Jain | 01903486 | Synchem Pharmaceuticals Private Limited | Whole-Time Director |
| Manish Jain | 01518865 | Synchem Pharmaceuticals Private Limited , Muskan Petro Chemical Llp | Whole-Time Director |
| Saurabh Jain | 10843269 | Muskan Petro Chemical Llp | Designated Partner |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Dharmendra Jain
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Dharmendra Jain
Dharmendra Jain currently holds 2 directorships: Synchem Pharmaceuticals Private Limited (Managing Director, since 19 Apr 2000, revenue ₹53.59 Cr (FY 2025)); Muskan Petro Chemical Llp (Designated Partner, since 20 Nov 2024).
Dharmendra Jain was first appointed on 19 Apr 2000 as Managing Director at Synchem Pharmaceuticals Private Limited. The most recent appointment on record is 20 Nov 2024 at Muskan Petro Chemical Llp.
The current boards of Dharmendra Jain's companies include Dinesh Kumar Jain (Synchem Pharmaceuticals Private Limited), Manish Jain (Synchem Pharmaceuticals Private Limited), Saurabh Jain (Muskan Petro Chemical Llp).